Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy

被引：229

作者：

Furuya, H

FernandezSalguero, P

Gregory, W

Taber, H

Steward, A

Gonzalez, FJ

Idle, JR

机构：

[1] MED SCH NEWCASTLE UPON TYNE,DEPT PHARMACOL SCI,PHARMACOGENET RES UNIT,NEWCASTLE TYNE NE2 4HH,TYNE & WEAR,ENGLAND

[2] NIH,NCI,MOLEC CARCINOGENESIS LAB,BETHESDA,MD 20892

[3] GENOTYPE LTD,NEWCASTLE TYNE NE2 4HE,TYNE & WEAR,ENGLAND

来源：

PHARMACOGENETICS | 1995年 / 5卷 / 06期

关键词：

genetic polymorphism; CYP2C9; warfarin; anticoagulation therapy;

D O I：

10.1097/00008571-199512000-00008

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：389 / 392

页数：4

共 11 条

[1] STEREOSELECTIVE INTERACTION BETWEEN THE R-ENANTIOMER OF WARFARIN AND CIMETIDINE
CHOONARA, IA
CHOLERTON, S
HAYNES, BP
BRECKENRIDGE, AM
PARK, BK
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 (03) : 271 - 277
[2] STANDARDIZED INITIAL WARFARIN TREATMENT - EVALUATION OF INITIAL TREATMENT RESPONSE AND MAINTENANCE DOSE PREDICTION BY RANDOMIZED TRIAL, AND RISK-FACTORS FOR AN EXCESSIVE WARFARIN RESPONSE
DOECKE, CJ
COSH, DG
GALLUS, AS
[J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1991, 21 (03): : 319 - 324
[3] FREDRIKS DA, 1991, CLIN PHARMACY, V10, P923
[4] FURIE B, 1992, NEW ENGL J MED, V326, P800
[5] PHARMACOGENETIC PHENOTYPING AND GENOTYPING - PRESENT STATUS AND FUTURE POTENTIAL
GONZALEZ, FJ
IDLE, JR
[J]. CLINICAL PHARMACOKINETICS, 1994, 26 (01) : 59 - 70
[6] KAMINSKY LS, 1993, MOL PHARMACOL, V43, P234
[7] CDNA AND AMINO-ACID-SEQUENCES OF 2 MEMBERS OF THE HUMAN P450IIC GENE SUBFAMILY
KIMURA, S
PASTEWKA, J
GELBOIN, HV
GONZALEZ, FJ
[J]. NUCLEIC ACIDS RESEARCH, 1987, 15 (23) : 10053 - 10054
[8] THE EFFECT OF THE PLASMA-LEVELS OF PROTEIN-C AND PROTEIN-S ON THE PREDICTION OF WARFARIN MAINTENANCE DOSE REQUIREMENTS
LUBETSKY, A
SELIGSOHN, U
EZRA, D
HALKIN, H
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (01) : 42 - 49
[9] A GENETIC ALGORITHM TO IMPROVE A NEURAL NETWORK TO PREDICT A PATIENTS RESPONSE TO WARFARIN
NARAYANAN, MN
LUCAS, SB
[J]. METHODS OF INFORMATION IN MEDICINE, 1993, 32 (01) : 55 - 58
[10] HYDROXYLATION OF WARFARIN BY HUMAN CDNA-EXPRESSED CYTOCHROME-P-450 - A ROLE FOR P-4502C9 IN THE ETIOLOGY OF (S)-WARFARIN DRUG-INTERACTIONS
RETTIE, AE
KORZEKWA, KR
KUNZE, KL
LAWRENCE, RF
EDDY, AC
AOYAMA, T
GELBOIN, HV
GONZALEZ, FJ
TRAGER, WF
[J]. CHEMICAL RESEARCH IN TOXICOLOGY, 1992, 5 (01) : 54 - 59

← 1 2 →